Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma

Beitrag in einer Fachzeitschrift


Details zur Publikation

Autor(en): Proske J, Walter L, Bumes E, Hutterer M, Vollmann-Zwerenz A, Eyüpoglu IY, Savaskan NE, Seliger C, Hau P, Uhl M, Walter L
Zeitschrift: Anticancer Research
Jahr der Veröffentlichung: 2016
Band: 36
Heftnummer: 3
Seitenbereich: 899-905
ISSN: 0250-7005


Abstract


The combination of radiotherapy, temozolomide and valproic acid (VPA) has shown some promise in retrospective analyses of patients with glioblastoma, although their mechanisms of action remain unknown.We investigated the in vitro and in vivo effects of pretreating glioma cells with temozolomide and VPA as an immunization strategy to boost an adaptive immune response in a syngeneic mouse model.Temozolomide and VPA induced autophagy in GL261 glioma cells, and caused tumor antigen-specific T-cells to become activated effector T-cells. Mice with a pre-existing glioma showed no improvement in clinical outcome when immunized with temozolomide- and VPA-treated glioma cells.Although temozolomide and VPA treatment of glioma cells can boost the adaptive immune response, in the context of a vaccine therapy, additional factors are necessary to eradicate the tumor and improve survival.



FAU-Autoren / FAU-Herausgeber

Eyüpoglu, Ilker Yasin Prof. Dr.
Neurochirurgische Klinik
Walter, Lisa Dr.
Lehrstuhl für Informatik 14 (Maschinelles Lernen und Datenanalytik)


Zitierweisen

APA:
Proske, J., Walter, L., Bumes, E., Hutterer, M., Vollmann-Zwerenz, A., Eyüpoglu, I.Y.,... Walter, L. (2016). Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma. Anticancer Research, 36(3), 899-905.

MLA:
Proske, Judith, et al. "Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma." Anticancer Research 36.3 (2016): 899-905.

BibTeX: 

Zuletzt aktualisiert 2018-19-04 um 04:18